Vascular Diseases: Clinical Trials

2,037 trials for Vascular Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2037 completed. 2037 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42037Completed 2037

Follow Vascular Diseases: new trials by email Literature Review of Vascular Diseases trials Research Report on Vascular Diseases

Trials (filtered) newest first · largest first

All 2,037 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Randomized, Controlled Study to Investigate the 12-month Efficacy and Safety of Resveratrol Vitamin Supplements in Patients With Non-proliferative Diabetic Retinopathy Without Center Involved Diabetic Macular Edema (REVOLUTION Study)
Resveratrol-Containing Vitamin Supplement - Diabetic Retinopathy, Non Proliferative Diabetic Retinopathy
Phase 4CompletedUniversity of Athens1002026-09-302026-10-09
Patient Comfort Following Intravitreal Injections Using Iheezo Versus Standard Anesthesia
Iheezo, Lidocaine pledget - Macular Degeneration, Diabetic Retinopathy
Phase 4CompletedRetina Consultants of Delmarva502026-05-202026-08-21
Oliceridine Versus Sufentanil for Blood Pressure Control During Anesthesia Induction in Older Women With Hypertension Undergoing Gynecological Laparoscopic Surgery
Oliceridine, Sufentanil - Hypotension, Hypertension
Phase 4CompletedXingguo Xu1342026-05-152026-10-13
ATILA Project: Aspirin Versus Tirofiban in Endovascular Treatment for Patients With Acute Ischemic Stroke Due to Tandem Lesion
Tirofiban, Acetylsalicylic acid - Acute Ischemic Stroke
Phase 4CompletedFundación Pública Andaluza para la gestión de la Investigación en Sevilla2402026-03-202026-04-03
Prophylactic Ondansetron for Preventing Spinal Anesthesia-Induced Hypotension in Elective Cesarean Section
Ondansetron, Placebo (0.9% Sodium Chloride) - Hypotension, Spinal Anesthesia
Phase 4CompletedSaglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital962026-02-022026-10-21
Early Administration of PCSK9 Inhibitors After Thrombectomy for Atherosclerotic Acute Ischemic Stroke: A Randomized Controlled Trial
Evolocumab(420 mg injections) - Acute Stroke
Phase 4CompletedThe Affiliated Hospital of Xuzhou Medical University602025-12-202026-07-13
Intraosseous Versus Intravenous Vancomycin in Below-Knee Amputation for Ischemic Diabetic Foot
Intraosseous Vancomycin, Intravenous Vancomycin - Diabetic Foot Disease, Diabetic Foot Infection
Phase 4CompletedBaşakşehir Çam & Sakura City Hospital402025-08-062026-07-10
Vitamin D Therapy to Prevent Recurrent Preeclampsia in High-Risk Pregnancies
Vitamin D (Cholecalciferol ), Placebo - Preeclampsia
Phase 4CompletedCMH Multan Institute of Medical Sciences1462025-08-012026-07-21
Intravenous Atropine in Reducing Reperfusion Arrhythmias, Conduction Abnormalities and Hypotension in Inferior ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
Intravenous atropine immediately before wire crossing during primary percutaneous coronary intervention, Intravenous normal saline as placebo immediately before wire crossing during primary percutaneous coronary intervention - Myocardial Infarction
Phase 4CompletedAin Shams University1582025-08-012026-03-10
Nonhealing Diabetic Foot Ulcers Treated With Standard of Care (SOC) Alone or Standard of Care and Amnion-Intermediate-Chorion (AIC)
Amnion-Intermediate-Chorion, Standard of Care (SOC) - Diabetic Foot Ulcer
Phase 4CompletedCellution Biologics842025-07-032026-08-20
Empagliflozin Versus Non-SGLT2 Oral Drugs for Blood Pressure in Type 2 Diabetes
Empagliflozin, Metformin - Type 2 Diabetes Mellitus, Hypertension
Phase 4CompletedDr. Zarmina Younes3002025-06-092026-04-21
Brimonidine 0.33% for Rosacea-Related Facial Erythema
Brimonidine 0.33% gel, Placebo gel - Rosacea, Rosacea Subtype 1 (Erythematotelangiectatic)
Phase 4CompletedIstanbul Training and Research Hospital452025-05-012026-02-24
Safety Study in Subjects ≥ 12 Years of Age With Hereditary Angioedema Switching to Garadacimab
Garadacimab - Hereditary Angioedema
Phase 4CompletedCSL Behring182025-04-282026-07-23
Norepinephrine ED90 Bolus After Spinal Anesthesia in Cesarean Section
Norepinephrine - Hypotension, Hypertension
Phase 4CompletedPontificia Universidad Catolica de Chile602025-04-012025-08-29
Evaluation of the Effectiveness of a Topical Medical Device in Wound Healing and Symptom Relief in the Postoperative Period of Open Excisional Hemorrhoidectomy (The Emor Study)
Gel containing a Propionibacterium extract, Hyaluronic acid and silver sulfadiazine - Anus Diseases, Gastrointestinal Diseases
Phase 4CompletedUniversity of Cagliari1142025-03-042025-07-02
Antithrombotic Activities of Sotagliflozin vs. Empagliflozin
Sotagliflozin, Empagliflozin - Thrombosis
Phase 4CompletedIcahn School of Medicine at Mount Sinai172025-02-252026-04-30
Evaluating the Effects of Nitroglycerin on Heart Function and Urinary Output in Patients With Acute Heart Failure
Nitroglycerin (NTG) - Acute Heart Failure (AHF)
Phase 4CompletedCopenhagen University Hospital, Hvidovre212025-02-012026-03-18
Nicardipine vs. Labetalol
nicardipine intravenous, labetalol intravenous - Acute Ischemic Stroke, Hypertensive Crisis
Phase 4CompletedHaseki Training and Research Hospital342025-02-012025-12-11
The Effect of Colchicine on the Occurrence of Atrial Fibrillation After Cardiac Surgery
NSAID, Colchicine 0.5 MG - Coronary Artery Disease, Atrial Fibrillation
Phase 4CompletedTomsk Cardiology Research Institute1402025-01-202026-09-30
Perioperative Nitric Oxide Prevents Acute Kidney Injury in Acute Type A Aortic Dissection Patients
Nitric Oxide, Placebo - Acute Kidney Injury, Nitrous Oxide
Phase 4CompletedBeijing Anzhen Hospital1062024-11-302026-02-05

Showing 20 of 2037. Sign in to see all of them.

Narrower conditions

Hypertension (469)  ·  Coronary Artery Disease (360)  ·  Myocardial Infarction (124)  ·  Acute Coronary Syndrome (115)  ·  Stroke (115)  ·  Diabetes Mellitus, Type 2 (104)  ·  Coronary Disease (98)  ·  Atherosclerosis (89)  ·  Diabetes Mellitus (87)  ·  Cardiovascular Diseases (74)  ·  Thrombosis (66)  ·  Myocardial Ischemia (63)  ·  Ischemic Stroke (61)  ·  Hypotension (52)  ·  ST Elevation Myocardial Infarction (50)

Broader conditions

Cardiovascular Diseases (1963)  ·  Heart Diseases (806)  ·  Myocardial Ischemia (695)  ·  Pathological Conditions, Signs and Symptoms (587)  ·  Arterial Occlusive Diseases (493)  ·  Arteriosclerosis (479)  ·  Pathologic Processes (433)  ·  Coronary Disease (354)  ·  Nutritional and Metabolic Diseases (290)  ·  Nervous System Diseases (288)  ·  Metabolic Diseases (276)  ·  Central Nervous System Diseases (250)  ·  Brain Diseases (248)  ·  Cerebrovascular Disorders (230)

Interventions

Clopidogrel (137)  ·  Aspirin (115)  ·  Amlodipine (95)  ·  Ticagrelor (89)  ·  Hydrochlorothiazide (83)  ·  Valsartan (70)  ·  Atorvastatin (61)  ·  Prasugrel Hydrochloride (48)  ·  Telmisartan (39)  ·  Rosuvastatin Calcium (35)  ·  Sodium Chloride (32)  ·  Rivaroxaban (31)  ·  Losartan (30)  ·  Nebivolol (30)  ·  Metoprolol (29)

Sponsors

Novartis (55)  ·  Sanofi (32)  ·  University of Florida (32)  ·  Boehringer Ingelheim (28)  ·  Deutsches Herzzentrum Muenchen (26)  ·  Novartis Pharmaceuticals (25)  ·  Yonsei University (23)  ·  Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (20)  ·  Seung-Jung Park (20)  ·  Seoul National University Hospital (18)  ·  Assistance Publique - Hôpitaux de Paris (15)  ·  Organon and Co (15)  ·  Cordis US Corp. (14)  ·  Daiichi Sankyo (14)  ·  Radboud University Medical Center (14)

Countries

United States (490)  ·  South Korea (181)  ·  China (179)  ·  Germany (138)  ·  Canada (121)  ·  Italy (109)  ·  France (105)  ·  United Kingdom (93)  ·  Spain (88)  ·  Japan (71)  ·  Brazil (70)  ·  Netherlands (70)  ·  Switzerland (67)  ·  Denmark (61)  ·  Austria (53)

Top investigators

Adnan Kastrati, MD (21)  ·  Seung-Jung Park, MD, PhD (13)  ·  Dominick J Angiolillo, MD, PhD (8)  ·  Albert Schoemig, MD (7)  ·  Albert Schomig, MD (7)  ·  David Antoniucci, MD (6)  ·  Herbert B Slade, MD (6)

Results publications

PMID 40875095, PMID 35224730, PMID 38018702, PMID 38682786, PMID 42573020, PMID 17261652, PMID 32588238, PMID 32905623, PMID 35244208, PMID 36398903, PMID 11519503, PMID 11786451, PMID 12221155, PMID 16271642, PMID 16731270, PMID 17964349, PMID 18307999, PMID 18757238, PMID 18765162, PMID 19264239, PMID 19482214, PMID 19577985, PMID 19717846, PMID 19737719, PMID 20031730, PMID 20231231, PMID 20554978, PMID 20606150, PMID 20650436, PMID 21232664, PMID 21459430, PMID 21873419, PMID 22007612, PMID 22070834, PMID 22440496, PMID 22496084, PMID 22837373, PMID 22922414, PMID 23868944, PMID 24251360, PMID 24291273, PMID 24768873, PMID 25173339, PMID 25249586, PMID 25635593, PMID 25721728, PMID 25940520, PMID 26689707, PMID 26823484, PMID 27513651

NIH funding

2009 (13), 2014 (11), 2015 (5), 2005 (4), 2018 (4), 2016 (3), 2004 (2), 2008 (2), 2017 (2), K23HL105897 (2), 1IK2CX002368-01A1 (1), 1RC3NS070646-01 (1), K23DK068223 (1), K23HL086558 (1), K23HL151871 (1)